| Financial Year |
March 31 2023 |
| Monetary Funds |
4,972,236,406.64 |
| Held-for-trading Financial Assets |
291,526,263.01 |
| Notes Receivable |
721,082,637.27 |
| Accounts Receivable |
7,189,129,036.22 |
| Advances to Suppliers |
121,119,667.17 |
| Other Receivables |
479,348,762.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
9,165,415,338.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,128,137,051.24 |
| Total Current Assets |
24,107,469,075.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
368,872,818.54 |
| Investment Properties |
1,789,304,139.39 |
| Fixed Assetes |
4,073,496,425.72 |
| Under-construction Projects |
50,255,035.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,865,526,881.57 |
| R&D expenses |
-- |
| Goodwill |
33,572,550.81 |
| Long-Term Deferred and Prepaid Expenses |
276,549,948.45 |
| Deferred Income Tax Assets |
412,184,935.80 |
| Other Non-Current Assets |
345,683,016.55 |
| Sub-Total of Non-Current Assets |
9,842,386,681.22 |
| Total Assets |
33,949,855,756.76 |
| Short-Term Loans |
3,653,161,569.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
859,833,623.41 |
| Accounts Payable |
8,475,320,441.74 |
| Accounts Received In Advance |
10,706,000.93 |
| Employee Compensation Payable |
607,188,480.56 |
| Taxes Payable |
721,056,892.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,282,163,283.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,233,994,709.53 |
| Other Current Liabilities |
843,981,796.19 |
| Sub-Total of Current Liabilities |
23,093,841,834.81 |
| Long-term Loans |
748,175,182.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
858,052,556.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
29,138,023.90 |
| Deferred Income Tax Liabilities |
408,061,222.81 |
| Other Non-Current Liabilities |
38,376,215.84 |
| Sub-Total of Non-Current Liabilities |
2,387,338,332.02 |
| Total Liabilities |
25,481,180,166.83 |
| Paid-In Capital(Or Share Stock) |
4,529,566,980.00 |
| Capital Surplus |
4,482,187,253.53 |
| Surplus Reserve |
99,143,044.95 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-6,266,914,543.23 |
| Minority Stockholder's Interest |
5,901,354,507.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,567,321,082.19 |
| Owner's Equity（Stockholder's Equity） |
8,468,675,589.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
33,949,855,756.76 |
